Table 2.
Follow-up periods | P value | |||||
---|---|---|---|---|---|---|
Baseline | 2 weeks | 4 weeks | P1 | P2 | P3 | |
Treatment group (N = 25) | 7.12 ± 1.20 | 7.80 ± 1.12 | 8.79 ± 1.73 | 0.88 | 0.01 | 0.07 |
Placebo group (N = 25) | 7.28 ± 1.46 | 7.36 ± 1.41 | 7.50 ± 1.47 | 0.96 | 0.91 | 0.94 |
P value | 0.86 | 0.26 | 0.02 |
P1 baseline versus 2 weeks; P2 baseline versus4 weeks; and P3 2 weeks versus 4 weeks.